01/11/2014 10:08:03 Free Membership Login

ARK Therapeutics Company Financial Information

 Company name: Ark Ther Grp
 EPIC: AKT Trading Currency: GBX
 Market Sector: ON10 ISIN: GB0034251727
 Market Segment: SET3 Share Type: DE
 WWW Address: http://www.arktherapeutics.com/ Description: ORD 1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 0.54 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 1.12 209.28 -0.01 0.50 - 1.07 - 0.58 - -

ARK Therapeutics Key Figures

(at previous day's close)
Market Cap.1.12m
Shares In Issue209.28m
Prev. Close0.54
PE Ratio1.07 
Dividend Yield-%
EPS - basic0.50p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.76p
Return On Equity (ROE)119.80%
Operating Margin-%
PEG Factor-0.01 
EPS Growth Rate-91.94%
Dividends PS Growth Rate-%
Net Debt-0.69m
Gross Gearing6.51%
Quick Assets0.98m
Net Working Capital0.92m
Intangibles / Fixed Assets-%
Turnover PS-p
Pre-Tax Profit PS-0.52p
Retained Profit PS0.53p
Cash PS0.36p
Net Cash PS0.33p
Net Tangible Asset Value PS *0.44p
Net Asset Value PS0.44p
Spread- (-%) 

ARK Therapeutics Balance Sheet

LSE:AKT:Liabilities+EQLSE:AKT:Assets

ARK Therapeutics Share Price

Sample Period HighLow
1 week--
4 weeks--
12 weeks--
1 year0.58-

ARK Therapeutics Share Price (5 years)

ARK Therapeutics Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week-0.54----
4 weeks-0.54----
12 weeks-0.54----
26 weeks-0.54----
1 year0.360.1848.610.391.260.39
3 years3.93-3.39-86.371.911.011.09
5 years41.00-40.47-98.704.730.722.79

ARK Therapeutics Key Management Ratios

ARK Therapeutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio1.07 
Tobin's Q Ratio 0.33 
Tobin's Q Ratio (excl. intangibles)0.36 
Dividend Yield-%
Market-to-Book Ratio1.22 
Price-to-Pre-Tax Profit PS-1.03 
Price-to-Retained Profit PS1.02 
Price-to-Cash Flow PS-0.70 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS1.22 
Price-to-Cash PS1.48 
Net Working Capital PS0.44 
Price Pct to Working Capital PS1.22%
Earnings Yield93.46%
Average PE0.85 
Years in average4 
PE to PE average126.15%

ARK Therapeutics Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-70.60%
Net Gearing (excl. Intangibles)-70.60%
Gross Gearing6.51%
Gross Gearing (excl. Intangibles)6.51%
Gearing Under 1 Year6.51%
Gearing Under 1 Year (excl. Intgbl)6.51%
Assets/Equity1.07 
Cash/Equity82.48 
(Liquidity Ratios)
Net Working Capital to Total Assets93.49%
Current Ratio15.36 
Quick Ratio (Acid Test)15.36 
Liquidity Ratio11.84 
Cash & Equiv/Current Assets77.11%
(Solvency Ratios)
Enterprise Value0.36m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-1.62 
CFO/Debt-24.84 
Total Debt/Equity Market Value0.06 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.06 
Total Debt0.06m
Total Debt/Net Current Assets0.07%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-0.0055-0.4757
Alpha (60-Mnth)Alpha (36-Mnth)
-0.0493-0.0295

ARK Therapeutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-118.82%
Return On Assets (ROA)32.90%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)119.80%
Return On Investment (ROI)50.06%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio59.97%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

ARK Therapeutics Dividends

Sorry No Data Available

ARK Therapeutics Fundamentals

 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
turnover0.76-7.13100.00%1.82100.00%--m
pre tax profit-16.94--4.44-62.34%-12.96-713.04%-1.09-m
attributable profit-16.17--3.45-48.39%-12.73-700.44%1.10-m
retained profit-16.17--3.45-48.39%-12.73-700.44%1.10-m
eps - basic8.00 2.00 6.20 0.50 
eps - diluted8.00 2.00 6.20 0.50 
dividends per share- - - - 

ARK Therapeutics Balance Sheet

 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
LSE:AKT:Liabilities+EQLSE:AKT:AssetsLSE:AKT:Liabilities+EQLSE:AKT:AssetsLSE:AKT:Liabilities+EQLSE:AKT:AssetsLSE:AKT:Liabilities+EQLSE:AKT:Assets
 31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
ASSETS
fixed assets fixed assets9.1137.46%6.7033.26%2.7047.22%--m
intangibles intangibles1.947.96%1.798.87%0.437.48%--m
fixed investments fixed investments--%--%--%--m
current assets - other current assets - other1.004.10%--%--%--m
stocks stocks--%0.231.15%0.122.05%--m
debtors debtors4.5618.75%1.939.59%0.417.25%0.23-m
cash & securities cash & securities7.7231.73%9.5047.13%2.0636.00%0.76-m
TOTAL24.33100%20.15100%5.71100%0.98100%m
LIABILITIES
creditors - short creditors - short3.9116.07%3.8619.15%2.2339.04%0.06-m
creditors - long creditors - long1.626.64%0.864.27%0.7312.73%--m
creditors - other creditors - other--%--%--%--m
subordinated loans subordinated loans--%--%--%--m
insurance funds insurance funds--%--%--%--m
TOTAL5.5322.72%4.7223.41%2.9651.78%0.06-m
EQUITY
ord cap, reserves ord cap, reserves18.8077.28%15.4376.59%2.7548.22%0.92-m
prefs, minorities prefs, minorities--%--%--%--m
TOTAL18.8077.28%15.4376.59%2.7548.22%0.92-m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

ARK Therapeutics Cash Flow Statement

31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)31 Dec 2013 (GBP)
Operating CF-10.73-1.65-7.40-1.59m
Pre-Financing CF0.851.74-7.30-0.90m
Retained CF0.831.75-7.48-0.90m

ARK Therapeutics Brokers

NameActivityTypeMnemonicCode
Nomura Code Securities LimitedMarket Maker(MME)Broker/DealerCODECODCGB21
CREDIT SUISSE SEC (EUROPE) LTDMarket Maker(MME)Broker/DealerCSFBCSFBGB2L
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MME)Broker/DealerJEFFJEFFGB2X
Piper Jaffray LtdMarket Maker(MME)Broker/DealerPIPRPIPRGB21
Numis Securities LimitedMarket Maker(MME)Broker/DealerNUMSRAZHGB2LBIC
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse akt141101 10:08